1,4-Di[3-(3-isothiocyanatophenyl)thioureido]butane
CAS: 711019-86-2
Rif. 3D-FI32757
5mg | Fuori produzione | ||
10mg | Fuori produzione | ||
25mg | Fuori produzione | ||
50mg | Fuori produzione |
Informazioni sul prodotto
1,4-Di[3-(3-isothiocyanatophenyl)thioureido]butane (PTI) is a small molecule that is used as a research tool to investigate the role of receptor tyrosine kinases in cancer. PTI inhibits the activity of tyrosine kinase, which prevents the growth and spread of cancer cells. PTI has been shown to have anti-tumour effects in cell cultures and animal models. It has also been shown to induce deformation in lung cancer cells and latency in T cells, making it an important drug for treating lung cancer. PTI can be administered orally or intravenously, with visible effects observed after administration.